NCT01240226View on ClinicalTrials.gov

A Study to Determine the Relative Bioavailability of a Tablet Formulation of GDC-0941 and the Effect of Ketoconazole on the Pharmacokinetics of the GDC-0941 Tablet

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Healthy Volunteer
Interventions
DRUG

GDC-0941

Oral repeating dose

DRUG

GDC-0941

Oral repeating dose

DRUG

ketoconazole

Oral repeating dose

Trial Locations (1)

78744

Investigational Site, Austin

Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY